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Toxoplasmosis is a protozoal parasitic infection with serious consequences for immunocompromised people. The 
commercial pharmaceuticals used for treatment cause adverse effects and cannot provide a 100% cure. We investigated on 
antitoxoplasmal activities of eleven medicinal plants from seven different families used in the Al Qassim region of Saudi 
Arabia against infectious diseases. The plants were extracted in methanol. The methanolic extracts were evaluated against 
Toxoplasma gondii and the Vero cell line using the MTT assay. The results obtained revealed the maximum inhibitory 
effects of extracts of Citrullus colocynthis, Blepharis ciliaris and Aerva javanica with IC50 values of 27.7, 65.2 and 78 
µg/ml, respectively against the parasite. However, at the effective levels of antitoxoplasmal activity extracts, of all the above 
plant species showed different degrees of cytotoxicity against the Vero cell line with SI values of 1.3, 0.8 and 1.1. Hence, 
we suggest further studies to isolate the active ingredients are highly recommended. 
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Natural product research shows the potential to serve 
as a niche for novel active ingredients, and plants in 
particular are regarded as highly valuable sources for 
the screening of bioactive compounds against various 
pathological conditions, including parasitic diseases. 
For instance, Citrullus colocynthis has also been 
subjected to phytochemical analysis and applied 
traditionally in many countries for the eradication of 
various diseases such as diabetes, cancer, enteric 
conditions, arthritis, respiratory inflammation and 
mastitis
1-5
. Similarly, plants of the genus Aerva and 
Blepharis have been used as medicinal herbs in 
several traditional systems of medicine all over the 




Toxoplasmosis is a cosmopolitan protozoal 
parasitic infection with serious symptoms, particularly 
for immunocompromised people
9-11
. In cases of 
efficient immunity there are no symptoms associated 
with the disease, but in people of insufficient immune 
system the disease becomes more fatal with sever and 
dangerous symptoms. In Saudi Arabia, there is no 
national systemic serological toxoplasmosis screening 
program; however, some researchers have conducted 
studies on the sero prevalence in many areas inside 
the country. These studies indicated that the sero 
prevalence ranges between 25 and 51.4% in different 
regions of Saudi Arabia
12-19
. The best medication for 
anti-Toxoplasma must be efficient against all the 
stages of the parasites with ability to penetrate inside 
the cysts as well as its ability to pass via placental 
barriers and without maternal and fetal toxicity and 
free from teratogenicity. Never the less, all the 




With this mentioned information, the current work 
is planned for the evaluation of the in vitro anti-
Toxoplasma activity of a select group of 11 medicinal 
plants from 4 orders and 7 families in the Al Qassim 
region to explore new, affordable and sustainable 
therapeutic treatments against Toxoplasma gondii. 
The plants were also tested for their potential 




Plant samples and preparation of extracts  
The selected plants were collected from the fields 
in and around the Al Qassim region during their 
growing seasons (Table 1). Subsequently, the 
collected plants were identified and authenticated by a 
————— 
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Table 1 — Plants subjected for the present work 
# Plant Name and Family Common name Speciemn 
Number 








HBQU-041511 Najd, South Hejaz, 
Eastern and 
Southern Regions. 
Alkaloids, saponins, tannins, 
steroids, terpenoids, 
flavonoids, glycosides, 







2 Salsola imbricate 
(Chenopodiaceae) 
(Ar.) Khareit SIQU-041512 Najd, South  










3 Bassia eriophora 
(Chenopodiaceae) 
(Ar.) Qutaynah BEQU-041513 Widespread Alkaloids, carbohydrates, 
glycosides, phytosteroids, 
phenolic compounds, 









AJQU-041514 Widespread Hentriacontane, nonacosane, 
heptacosane, pentacosane, 
octacosane, triacontane and 
hexacosane, steroids, 
terpenoides, fats, flavonoids, 
tannins, saponins, alkaloids, 




5 Rumux vesicarius L. 
(Polygonaceae) 
 RVQU-041515  Proteins, organic acids 
(malic, citric, oxalic acids), 





tooth pain,  against 
inflammation, 






















EAQU-041517 Najd, Nufud 
Region 
Flavonoids32 Not found  
8 Morettia parviflora 
(Brassicaceae) 
(Ar.) Rabol MPQU-041518 Najd, North Hejaz, 
Southern Region. 
Not Found Not Found  









10 Citrullus colocynthis 
(L.)Schrad in L. 
(Cucurbitaceae) 
 CCQU-041520  Flavonoid quercetin, Flavone 
c-glucosides and other 
alcohols, ketones, acids, 






11 Blepharis ciliaris (L.) 
B.L. Burtt in Tackh. 
(Acanthaceae) 
 BCQU-041521  Phenols, apigenin glucoside, 
apigenincoumaroyl 
glucoside, flavones, 
flavonones and isoflavone 
glycoside caffeic acid ester. 
Antimicrobial,  
anti-inflammatory, 
treatment of cough 
and kidney 
disorders35. 




taxonomist and specimen vouchers were prepared and 
preserved at the Botany Department Herbarium, 
Qassim University, Saudi Arabia. The aerial parts 
(whole plants except the root) of collected plant 
material were shade dried, reduced to fine powder 
using a laboratory blender, passed through a 60-mesh 
sieve (BS), packed in screw caped containers then 
stored at 4°C in order to be used later
21
. 
The material of each plant (500 g) was soaked in 5 L 
of analytical grade methanol at 25°C temperature for 
overnight. Whatman No.1 filter paper was used for 
filtration of the extract. The residue was transferred to a 
container, extracted again with 2.5 L of fresh methanol 
for 16 h and then followed by filtration. Then all 
filtrates were pooled and evaporated under vacuum 
using a rotary vacuum evaporator at 45°C until dryness 
occurred. Then the weight of dried extract was 
calculated to note the yield % and stored in airtight 




Evaluation of the anti-Toxoplasma activity of crude extracts  
An active form of T. gondii RH strain was obtained 
from Dr. S. El-Ashram (State Key Laboratory for 
Agrobiotechnology, China Agricultural University, 
Beijing, 100193, China) and proliferated in a Vero cell 
line (ATCC® CCL-81™, USA). 100-cm
2
 culture flasks 
were used for culturing parasites in complete RPMI 
medium supplied with 10% fetal bovine serum (FBS) 
and then incubated at 37°C and 5% CO2. T. gondii 
tachyzoites (RH strain) were maintained, by serial 
passage, in Vero cells grown in RPMI medium with 
10% FBS. Tachyzoites were collected and preserved in 
liquid N2 at a concentration of 6 ×10
6 
parasites/ml. 
Plates of 96 wells were used for culturing Vero 
cells (5×10
3
 cells/well in 200 µL RPMI 1640 medium 
with 10% FBS) at 37°C and 5% CO2. Then one day 
later, after removing the medium, PBS was used for 
washing the cells and getting rid of non-adherent 
ones. After that, RPMI 1640 medium supplied by 2% 
FBS containing T. gondii tachyzoites at a parasite to 
cell ratio of 5:1 was added. Followed by incubation at 
37ᵒC and 5% CO2 to 4 h, then PBS was used for 
washing the cells to get rid from free parasites. The 
cells were then treated as described below in RPMI 
1640 medium with 2% FBS and incubated at 37°C 
and 5% CO2. 
 
1 Control Medium 
2 Positive Control Medium + Atovaquone (Reference: 
50, 25, 12.5, 6.25µg/ml) 
3 Experimental  Medium + Plant Extract (50, 25, 12.5, 
6.25µg/ml) 
After 72 h, toluidine blue with concentration of 1% 
was used for staining the cells. Inverted 
photomicroscope was used for the determination the 
T. gondii infection index (the number of cells infected 
from each 200). The inhibition percentages of the 
infection index were calculated according to the 
following equation. 
 
Inhibition % = ((1control-1experimental)/1control)  
X 100 
 
Wherein, I Control means the infection index in 
untreated cells, while I Experimental means the 
infection index in drug/extract-treated cells. IC50: 50% 
reduction of infected cells compared to the control 
cells (those exposed to culture medium alone, without 




Toxicological evaluation of crude extracts in vitro using the 
MTT assay 
Toxicological evaluations were performed to 
confirm the safety or toxicity of the plant extracts 
against the cells of the host according to the plant 
extract concentration that can be safely used without 
negatively affecting cell viability. Plates of 96-well 
were used for culturing Vero cells at concentration of 
5×10
3
 cells/well/200 µl for one day in complete RPMI 
1640 medium supplied by 10% FBS and 5% CO2 at 
37°C. PBS was used for washing the cells. The cells 
were treated with atovaquone for 72 h (positive 
control) or plant extracts at varying concentrations 
(50, 25, 12.5, 6.25 µg/ml) in 10 % completed medium 
with serum. This medium was used with cells as 
negative control. Then, supernatant was removed, and 
50 µl of plain RPMI 1640 medium with 14 µl of MTT 
(5 mg/ml) was applied, and allowed to stay at room 
temperature for incubation period of 4 h. Next, the 
supernatant again removed gently. For dissolving the 
water-insoluble formazan salt, 150 µl of DMSO was 
added. FLUO star OPTIMA spectrophotometer was 
used at 540 nm in order to read the colorimetric 
reaction values produced from MTT. Cytotoxic 
results were presented as the concentration that may 
give 50% reduction in the viability of the cells (CC50) 
compared to the control cells (those treated only with 





The data were presented as the mean ± SD of 
triplicate determinations. Wherever applicable, the 
data were analyzed by ANOVA and significant 
differences between the groups were analyzed  
by Tukey’s post hoc test. Values were considered 




significant at p ≤ 0.05 and p ≤ 0.001. IC50 values, 
wherever applicable evaluated by linear regression. 
 
Results and Discussion  
The anti-Toxoplasma assay demonstrated that all 
the plant extracts possess toxoplasma inhibitory 
properties of varying degrees.  
The maximum inhibitory percentage was recorded 
for C. colocynthis, which inhibited T. gondii up to 
84% with a 50 µg/ml concentration, while the 
minimum was recorded as 5% for B. eriophora at 
same extract concentration of 50 µg/ml. As expected, 
the inhibitory percentage decreased with decreases in 
extract concentration, with A. javanica having the 
highest antitoxoplasmal activity of 24% at 6.25 
µg/ml. Only 2 other plant had inhibitory percentages 
of ≤ 10%, while the remaining 8 plants were 
completely ineffective at the low extract 
concentration of 6.25 µg/ml as shown in Figure 1. 
The cytotoxicity assay revealed that all 11 plants 
extracts show varying degrees of cytotoxicity, ranging 
from 35% to 83% for the highest extract 
concentration of 50 µg/ml. The minimum extract 
concentration at which all the samples were cytotoxic 
was 12.5 µg/ml. However, at 6.25 µg/ml, 6 plant 
samples demonstrated cytotoxicity ranging from 2% 
(B. eriophora) to 16% (C. amblyocarpa and R. 
vesicarius), while the rest of the 5 samples were non 
cytotoxic. The cytotoxic trends are further elucidated 
in Figure 2. 
Calculations of the IC50, CC50 and Selectivity Index 
(SI) of the plant extracts highlighted the therapeutic 
efficacy of A. javanica and C. colocynthis with SI 
values of 1.111 and 1.317, respectively.  
 
The other 9 plant extracts demonstrated relatively 
low therapeutic efficacy with SI values falling below 
1. Although M. parviflora had a calculated SI value of 
less than 1.277, its higher CC50 value indicates that 
the extract is the least toxic among all 11 samples. 
Table 2 provides a detailed overview of the IC50, CC50 
and SI values for each plant extract. 
 
From time immemorial, medicinal plants have 
proved to be a better source for drug discovery and 
the elimination of various types of diseases
22
. Many 
of the highly active and efficient drugs against 
protozoan diseases were developed from the products 
of medicinal plants such as quinine and artemisinin
23
. 
In the present work a group of eleven medicinal plants 
commonly used locally in Al Qassim, KSA for the 
eradication of various types of infectious disease were 
examined for antiparasitic activity against the  
T. gondii RH strain in vitro. Among them, only  
C. colocynthis has an IC50 less than 30 µg/ml (27.7 
µg/ml), which indicates good activity and promising 
results for future isolation of the active ingredient/s. 
In previous studies, C. colocynthis proved to be very 
potent, with many types of biological activities, e.g., 
the crude ethanolic extracts of the aerial parts of the 
plant was found to possess potent antimicrobial 
 
 
Fig. 1 — Antitoxoplasmal activity of selected plant methanol extracts 




property against different types of standard and 
clinically isolated bacteria and fungi
24
. The plant is 
rich in groups of secondary metabolites such as 
polyphenols, glycosides and fatty acids, which were 





The cytotoxicity assay revealed that all 11 plants 
extracts show varying degrees of cytotoxicity, ranging 
from 35% to 83% for the highest extract 
concentration of 50 µg/ml. The minimum extract 
concentration at which all the samples were cytotoxic 
was 12.5 µg/ml. However, at 6.25 µg/ml, 6 plant 
samples demonstrated cytotoxicity ranging from 2% 
(B. eriophora) to 16% (C. amblyocarpa and  
R. vesicarius), while the rest of the 5 samples were 
non cytotoxic. The cytotoxic trends are further 
elucidated in Figure 2. 
 
Calculations of the IC50, CC50 and Selectivity Index 
(SI) of the plant extracts highlighted the therapeutic 
efficacy of A. javanica and C. colocynthis with SI 
values of 1.111 and 1.317, respectively.  
 
The other 9 plant extracts demonstrated relatively 
low therapeutic efficacy with SI values falling below 
1. Although M. parviflora had a calculated SI value of 
less than 1.277, its higher CC50 value indicates that 
the extract is the least toxic among all 11 samples. 
Table 2 provides a detailed overview of the IC50, CC50 
and SI values for each plant extract. 
 
From time immemorial, medicinal plants have 
proved to be a better source for drug discovery and 
the elimination of various types of diseases
22
. Many 
of the highly active and efficient drugs against 
protozoan diseases were developed from the products 
of medicinal plants such as quinine and artemisinin
23
. 
In the present work a group of eleven medicinal plants 
commonly used locally in Al Qassim, KSA for the 
eradication of various types of infectious disease were 
examined for antiparasitic activity against the  
T. gondii RH strain in vitro. Among them, only  
C. colocynthis has an IC50 less than 30 µg/ml (27.7 
µg/ml), which indicates good activity and promising 
results for future isolation of the active ingredient/s.  
 
 
Fig. 2 — Cytotoxic activity of selected plant methanol extract against the Vero cell line 
 
Table 2 — IC50 (antitoxoplasmal activity), CC50 (cytotoxicity) and 
SI of plant extracts 






1 Heliotropium bacciferum > 100 38.28 > 0.38 
2 Salsola imbricate >100 > 100 - 
3 Bassia eriophora >100 54.1 <0.54 
4 Aerva javanica 78 86.7 1.112 
5 Rumux vesicarius > 100 98.7 < 0.98 
6 Zilla spirosa >100 63.4 <0.63 
7 Eremobium aegyptiacum >100 29.04 <0.29 
8 Morettia parviflora > 100 >100 - 
9 Cleome amblyocarpa > 100 96.4 < 0.964 
10 Blepharis ciliaris 65.16 54.25 0.833 
11 Citrullus colocynthis 27.69 36.48 1.317 
 




In previous studies, C. colocynthis proved to be very 
potent, with many types of biological activities, e.g., 
the crude ethanolic extracts of the aerial parts of the 
plant was found to possess potent antimicrobial 
property against different types of standard and 
clinically isolated bacteria and fungi
24
. The plant is rich 
in groups of secondary metabolites such as 
polyphenols, glycosides and fatty acids, which were 





Therefore, we can consider the presence of these 
secondary metabolites in C. colocynthis as the major 
source for its antitoxoplasmal activity. We can 
conclude that C. colocynthis methanol extracts have 
good antitoxoplasmal activity, but further study for 
isolation of the active ingredient is highly 
recommended, particularly to avoid the cell toxicity 
observed in this study. 
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